Clinical trial
Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women
NCT00030914 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00030914 |
|---|---|
| Title | Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women |
| Official title | Phase III Comparison of Depomedroxyprogesterone Acetate (DPROV) to Venlafaxine for Managing Hot Flashes |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hot Flashes |
| Intervention type | Drug |
| Interventions | medroxyprogesterone, venlafaxine |
| Enrollment | 227 |
| Start date | Apr 1, 2002 |
| Primary completion | Feb 1, 2006 |
| Completion | Sep 1, 2006 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 13, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: